PPARδ agonist attenuates alcohol-induced hepatic insulin resistance and improves liver injury and repair

PPARδ agonist administration may attenuate the severity of chronic ethanol-induced liver injury and ethanol's adverse effects on the hepatic repair by restoring insulin responsiveness, even in the context of continued high-level ethanol consumption.